Henry Schein (HSIC)
(Delayed Data from NSDQ)
$73.21 USD
+0.45 (0.62%)
Updated Apr 24, 2024 04:00 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Henry Schein (HSIC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$79.64 | $90.00 | $65.00 | 8.78% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Henry Schein comes to $79.64. The forecasts range from a low of $65.00 to a high of $90.00. The average price target represents an increase of 8.78% from the last closing price of $73.21.
Analyst Price Targets (11)
Broker Rating
Henry Schein currently has an average brokerage recommendation (ABR) of 2.56 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 2.56 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, four are Strong Buy, representing 30.77% of all recommendations. A month ago, Strong Buy represented 30.77%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 7 | 7 | 5 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.56 | 2.56 | 2.56 | 2.56 | 2.48 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/28/2024 | Evercore Partners | Elizabeth Anderson | Not Available | Hold |
2/28/2024 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
2/26/2024 | Piper Sandler | Jason Bednar | Strong Buy | Strong Buy |
2/26/2024 | SVB Securities | Michael Cherny | Not Available | Hold |
11/14/2023 | Robert W. Baird & Co. | Jeffrey D Johnson | Not Available | Hold |
11/2/2023 | William Blair | Brandon Vazquez | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.56 |
ABR (Last week) | 2.56 |
# of Recs in ABR | 13 |
Average Target Price | $79.64 |
LT Growth Rate | 8.00% |
Industry | Medical - Dental Supplies |
Industry Rank by ABR | 69 of 252 |
Current Quarter EPS Est: | 0.99 |